Literature DB >> 4791489

Successful treatment of Pseudomonas cepacia endocarditis with trimethoprim-sulfamethoxazole.

J Hamilton, W Burch, G Grimmett, K Orme, D Brewer, R Frost, C Fulkerson.   

Abstract

A patient with a history of alcoholism and drug abuse who developed Pseudomonas cepacia endocarditis is described. The organism was found to be resistant in vitro to all common antimicrobial agents except chloramphenicol and trimethoprim-sulfamethoxazole. Treatment failed with penicillin and streptomycin and later with chloramphenicol. Orally administered trimethoprim-sulfamethoxazole, however, resulted in sterilization of the patient's blood and aortic valve which was resected 27 days after the start of therapy. A 6-week course of therapy was completed and, to date (6 months after treatment), there has been no recurrence.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4791489      PMCID: PMC444593          DOI: 10.1128/AAC.4.5.551

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Etiology of bacterial endocarditis. Before and since the introduction of antibiotics.

Authors:  L M WILSON
Journal:  Ann Intern Med       Date:  1963-06       Impact factor: 25.391

2.  Flavobacterium infection as a cause of bacterial endocarditis. Report of a case, bacteriologic studies, and review of the literature.

Authors:  J SCHIFF; L S SUTER; R D GOURLEY; W D SUTLIFF
Journal:  Ann Intern Med       Date:  1961-09       Impact factor: 25.391

3.  Acute bacterial endocarditis caused by a variant of the genus Herrellea.

Authors:  W B SORRELL; L V WHITE
Journal:  Am J Clin Pathol       Date:  1952-02       Impact factor: 2.493

4.  Surgical management of the complications of sepsis involving the aortic valve, aortic root, and ascending aorta.

Authors:  M J Buckley; E D Mundth; W M Daggett; W G Austen
Journal:  Ann Thorac Surg       Date:  1971-10       Impact factor: 4.330

5.  Esch. coli endocarditis successfully treated with oral trimethoprim and sulphamethoxazole.

Authors:  A S Fowle; P A Zorab
Journal:  Br Heart J       Date:  1970-01

6.  Pseudomonas cepacia endocarditis treated with co-trimoxazole and kanamycin.

Authors:  D C Speller
Journal:  Br Heart J       Date:  1973-01

7.  Colonization and infection with Pseudomonas cepacia.

Authors:  G M Ederer; J M Matsen
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

8.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

9.  Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy.

Authors:  S R Bushby
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

10.  Trimethoprim: laboratory and clinical studies.

Authors:  J H Darrell; L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

View more
  8 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Recurrent pneumonitis due to Pseudomonas cepacia. An unexpected phagocyte dysfunction.

Authors:  D Denney; R H Bigley; A L Rashad; W J MacDonald; M J Miller
Journal:  West J Med       Date:  1975-02

3.  Pseudomonas cepacia strains isolated from water reservoirs of unheated nebulizers.

Authors:  S M Gelbart; G F Reinhardt; H B Greenlee
Journal:  J Clin Microbiol       Date:  1976-01       Impact factor: 5.948

4.  Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.

Authors:  J E Rosenblatt; P R Stewart
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

5.  A case of native valve endocarditis caused by Burkholderia cepacia without predisposing factors.

Authors:  Hyun Kyun Ki; Sung Hea Kim; Seong Woo Han; Hae Suk Cheong
Journal:  BMC Infect Dis       Date:  2011-05-08       Impact factor: 3.090

6.  Association of Pseudomonas cepacia with chronic granulomatous disease.

Authors:  E J Bottone; S D Douglas; A R Rausen; G T Keusch
Journal:  J Clin Microbiol       Date:  1975-05       Impact factor: 5.948

7.  Endocarditis associated with Comamonas acidovorans.

Authors:  H Horowitz; S Gilroy; S Feinstein; G Gilardi
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

Review 8.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.